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Abstract: Introduction: Implementing Intermittent Preventive Treatment for malaria in Pregnancy (IPTp) with sulfadox-
ine-pyrimethamine (SP) through antenatal care (ANC) clinics is recommended for malaria endemic countries. Vast bio-
medical literature on malaria prevention focuses more on the epidemiological and cost-effectiveness analyses of the ran-
domised controlled trials carried out in selected geographical settings. Such studies fail to elucidate the economic, psycho-
social, managerial, organization and other contextual systemic factors influencing the operational effectiveness, compli-
ance and coverage of the recommended interventions.  
Objective: To review literature on policy advances, achievements, constraints and challenges to malaria IPTp implementa-
tion, emphasising on its operational feasibility in the context of health-care financing, provision and uptake, resource con-
straints and psychosocial factors in Africa. 
Results: The importance of IPTp in preventing unnecessary anaemia, morbidity and mortality in pregnancy and improving 
childbirth outcomes is highly acknowledged, although the following factors appear to be the main constraints to IPTp 
service delivery and uptake: cost of accessing ANC; myths and other discriminatory socio-cultural values on pregnancy; 
target users perceptions and attitudes towards SP, malaria, and quality of ANC; supply and cost of SP at health facilities; 
understaffing and demoralised staff; ambiguity and impracticability of user-fee exemption policy guidelines on essential 
ANC services; implementing IPTp, bednets, HIV and syphilis screening programmes in the same clinic settings; and re-
ports on increasing parasite resistant to SP. However, the noted increase in the coverage of the delivery of IPTp doses in 
several countries justify that IPTp implementation is possible and better than not.  
Conclusion: IPTp for malaria is implemented in constrained conditions in Africa. This is a challenge for higher coverage 
of at least two doses and attainment of the Abuja targets. Yet, there are opportunities for addressing the existing chal-
lenges, and one of the useful options is the evaluation of the acceptability and viability of the existing intervention guide-
lines. 
Key Words: Malaria, antenatal-care, intermittent-treatment, pregnancy, health services. 
INTRODUCTION  
Malaria in Pregnancy 
 Globally, malaria causes 300-500 millions cases of ill-
ness each year and is the leading cause of morbidity and 
mortality, especially among the pregnant women and chil-
dren under the age of five years (underfives) [1-4]. Of the 
estimated 1-3 million malaria deaths recorded globally each 
year, 90% occur in sub-Saharan Africa (SSA) [5, 6]. About  
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30 million women in malarious areas of SSA get pregnant 
each year, and the majority live in relatively stable malaria 
transmission [7]. Among other consequences, malaria in 
pregnancy can cause severe anaemia, stillbirths, spontaneous 
abortion, neonatal mortality, low child birth-weight, child’s 
brain damage and inter-uterine growth retardation [8-11].  
Intermittent Preventive Treatment of Malaria in Preg-
nancy (IPTp) 
 The World Health Organization (WHO) has recom-
mended the malaria-endemic countries to implement sul-
fadoxine-pyrimethamine (SP) for intermittent preventive 
treatment for malaria during pregnancy (IPTp) as one of the  
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essential services under the focused antenatal care service 
package [7, 12]. The recommendation specifies at least two 
doses to be administered, the first one during the second tri-
mester and the second dose during the third trimester of 
pregnancy [7, 12]. To ensure compliance in uptake of IPTp 
doses by the pregnant women attending antenatal care clinics 
(ANC), the guidelines emphasise on direct observed treat-
ment (DOT) by a qualified health worker [11, 13]. Respond-
ing to WHO’s call, SSA heads of state through the Abuja 
Declaration commonly agreed that each pregnant woman 
attending ANC clinics should receive two doses of IPTp 
during her pregnancy period and a subsidised insecticide 
treated net (ITN) [14-16]. While many countries have rec-
ommended two doses of SP for IPTp, there is still debate 
about giving three doses or more, particularly to pregnant 
women who book early and continue attending ANC regu-
larly [17], and to those who are HIV positive [15, 18]. Ow-
ing to evidence that two doses of IPTp with SP are inade-
quate to HIV infected women [19], multiple doses are rec-
ommended, especially in the primigravidæ [20, 21]. As de-
tailed below, the limiting factors include low ANC atten-
dance behaviours, fears about HIV tests, attitudes towards 
SP, and growing parasite resistance to SP, as detailed further 
below. 
Efficacy, Safety and Cost-Effectiveness of SP for Malaria 
Treatment 
 There are fears that SP may induce side-effects in areas 
with high prevalence of human immunodeficiency virus 
(HIV) infection [15, 18]. This being the case from a biologi-
cal perspective, it should be understood that the program-
matic effectiveness of an anti-parasitic drug is determined by 
the efficacy of that drug against the parasite and by the 
drug’s characteristics, including affordability, availability, 
acceptability to the target population, and deliverability in 
terms of dosing requirements and incorporation into existing 
ANC delivery systems [4]. Alarming resistance to SP in 
some parts of East Africa has been reported many years ago 
[22-26], and this contributed to current concerns about its 
effectiveness for IPTp [17]. Although P.falciparum strains 
contribute to SP resistance [25], poor prescription and con-
sumption practices in the health-care system lowers the ef-
fectiveness of malaria interventions, including IPTp [25, 27]. 
So far, there is lack of evidence on: how IPTp-SP works in 
areas of low and seasonal malaria transmission areas espe-
cially in areas where SP has lost its efficacy [17]; added 
benefit of giving more than two doses of IPTp to each preg-
nant woman regardless of their HIV or gravidity status, as 
already this has been noted of being less advantageous [28]; 
perceived and real benefits and acceptability of SP to the 
target populations given in the existence of parasite resis-
tance to SP especially in East and Southern Africa [11, 20, 
29]; the use of artemisinin-based combination therapies 
(ACTs) for IPTp considering costs and risks [11, 30, 31], and 
acceptability of SP for IPTp following replacement of SP by 
ACT in several countries (e.g. Tanzania) as the first-line 
drug for the treatment of uncomplicated malaria [32, 33].  
Objective and Scope of this Review 
 ANC clinics are the most common entry points for IPTp 
implementation [7, 12]. IPTp implementation through com-
munity-based health workers (HWs) and traditional birth 
attendants (TBAs) has been considered and tried out in Ma-
lawi [34] and Uganda [35-36] as a way of increasing cover-
age of IPTp and compliance. Experience from these two 
countries has shown that there have been some notable suc-
cesses. Logically, integrating IPTp into ANC structures is 
highly advantageous, but the effects of one on the other are 
often underestimated [37]. The factors influencing IPTp im-
plementation including the operational feasibility of IPTp 
and use of ANC services in general may be numerous and 
mutually non-exclusive [17, 34, 38]. Factors such as the per-
ceived cost, quality and benefits of ANC, and social values 
on pregnancy that makes women feel discriminated and hu-
miliated in some ways, gender relations in the society may 
influence the outcome, although they are rarely analysed and 
documented empirically partly due to methodological diffi-
culties [37]. Understanding the socio-cultural determinants 
of the use of malaria preventive services including those 
delivered through ANC clinics and of the compliance with 
drug uptake by the target populations is imperative [27]. So 
far, studies on social perceptions of health and disease, cul-
tural values and people’s ability to cope with the existing 
malaria interventions in constrained socio-economic and 
health system contexts are inadequate [39-41]. Other authors 
have suggested the following: 
•  evaluations of malaria prevention and treatment strate-
gies should consider the broad health service delivery 
contexts, including the motivation and behaviour of 
health service providers and the target service users [42, 
43]; 
• research-based evidence on how the recommended inter-
vention is implemented is crucial to enable elucidation of 
the specific underlying obstacles which policy decision 
authorities need to know in order to take appropriate pol-
icy actions [44].  
 This paper is a review focusing on the policy advances, 
constraints and challenges to malaria IPTp implementation, 
with emphasis on its operational feasibility in the context of 
health-care financing, provision and uptake, resource con-
straints and diverse psychosocial factors in SSA. Broad con-
textual factors currently affecting (or with potential effect 
on) women’s perceptions, attendance to, and use of ANC 
including IPTp, as well as health service providers’ attitudes, 
motivation and practice on ANC (and IPTp), are highlighted 
and discussed. Experiences from developing countries out-
side Africa on ANC provision, uptake and coverage similar 
to those of SSA, are cited, and lessons are drawn from pro-
grammes across Africa to feed into the current policy and 
inform the research agenda. The paper is based on peer-
reviewed and non-peer reviewed articles, including grey lit-
erature and official working papers published by various 
agencies/authorities.  
REVIEW METHODS 
 The articles reviewed in this paper were searched from 
the internet, based on the application of key words to make 
important downloads from the PubMed. Sometimes the 
search was done by typing the key words in Google first. 
The articles reviewed were downloaded selectively based on 
the contents of the information displayed. If the full articles 
could not be accessed directly, WHO HINARI system was 
consulted as done by other reviewers [11]. The search words 
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mostly used in relation to IPTp are: pregnancy, perceptions, 
malaria, treatment, chemoprevention, intermittent, and pre-
vention, while those used for searching for the broad aspects 
concerning ANC are: antenatal, provision, utilisation, de-
mand, cost, supply, quality, Africa, developing countries. 
The word AND was sometimes used to combine two or more 
search words so as to display the article(s) needed. Addi-
tional literature was obtained using email alerts from Bio-
Med Central for online full published articles, unpublished 
reports (some of which are accessible online), and hard cop-
ies of some articles found in journals documented at the local 
libraries, particularly at the National Institute for Medical 
Research (Tanzania), London School of Hygiene and Tropi-
cal Medicine (UK), DBL Centre for Health Research and 
Development and Faculty of Health Sciences at the Univer-
sity of Copenhagen (Denmark). Some articles were re-
quested directly from the original authors. Although efforts 
were made to ensure that all articles relevant for this review 
were considered without restriction on the dates of their pub-
lication, most of the articles cited have been published be-
tween 2000 and 2007. In some parts of the results section, 
the present paper begins by presenting an overview of the 
themes related to ANC or IPTp. Then, it goes down to spe-
cific issues addressing the determinants of ANC and IPTp 
service supply and demand, before the general discussions 
and conclusions.  
RESULTS 
Accessibility, Acceptability and Practicability of ANC 
and IPTp  
 Accessibility and coverage of malaria interventions in 
SSA are constrained by poverty, limited health infrastruc-
ture, ineffective drug policy regulations and other health-care 
market imperfections [14, 42, 45]. Strategies towards attain-
ing the Millennium Development Goals (MDGs) through 
scaling-up malaria control interventions are constrained by, 
among other factors, weak health systems, unclear and dis-
puted solutions weakly supported by evidence [46]. In 1996 
WHO reported that at least 40% pregnant women in devel-
oping countries receive no ANC and that nearly 31% deliver 
at home [47]. Coverage of IPTp in SSA varies from modest 
to low, as it is the case with ITNs [37]. In Blantyre (Malawi), 
it was found that 75.7% of 391 pregnant women who still 
were having ANC cards at household level had received at 
least one dose of IPTp, but only 36.8% received the second 
dose [15]. In the latter country, a previous study found that 
24% of the women were not prescribed SP and only 30% 
received at least two IPTp doses [48]. In rural Kenya, only 
19.1% of 635 study participating women reported having 
received SP for IPTp while only 6.8% had received two 
doses, despite 89.9% of the women having attended ANC 
[49]. At the Tanzanian National Malaria Control Programme 
(NMCP) level, records on IPTp showed that by March 2007 
the coverage of the first and second doses (based on sentinel 
survey of 21 districts) were 67% and 45%, respectively [33].  
 Contextual factors play a significant role in facilitating or 
constraining the effectiveness of any health intervention 
from the operational perspective. For instance, the effective-
ness of any malaria intervention depends on consumer and 
provider acceptance and compliance, safety, cost, integration 
with other interventions, local health care delivery system 
and the degree of combination of all these [50]. Institution-
alisation of public health interventions within constrained 
infrastructure, other supply and demand conditions is critical 
to the effectiveness of such interventions, and this has raised 
much concern in health policy programmes targeting the 
services to the populations in need [34, 42, 51, 52].  
Accessibility Barriers 
 In SSA, women’s late presentation at ANC is common, 
with nearly 25% of them presenting for the first time in the 
second trimester and for the second time during the third 
trimester, and this has contributed to lowering the effective-
ness of ANC and IPTp related services [7, 14, 15, 28, 53]. 
Rural residents are relatively more disadvantaged than their 
urban counterparts in terms of geographical and financial 
accessibility to ANC [12, 47], and generally the poorer 
women whether in rural or urban areas are more disadvan-
taged [7]. 
 Travel distance has continued being reported as one of 
the major challenges to women’s access to and utilisation of 
reproductive and child health (RCH) services [54-56]. Even 
if the RCH services were provided free of charge, the long 
travel distance leads to additional time cost, and in many 
cases, financial expenditures that overburden the poorer 
women who ultimately are dissuaded to attend clinics for 
ANC or childbirth [42, 57-64]. The timing of ANC atten-
dance is considered to increase the opportunity for the preg-
nant women to receive IPTp. However, a recent study in 
northern Tanzania found no association between early ANC 
attendance and uptake of IPTp, this suggesting that the ef-
forts to foster timely attendance alone are unlikely to im-
prove uptake of IPTp where other contextual barriers exist 
[32].  
Travel Distance to ANC Clinics by the Target Populations 
 Due to delays in contacting clinics for ANC, a large pro-
portion of SSA countries recommended four ANC visits and 
increased the spacing between them in conformity to WHO 
protocol [62]. The optimal number of ANC visits for coun-
tries with limited resources is still debated at policy and pro-
gramme levels [55]. Sometimes the target ANC women 
show more concern with the quality of care than the number 
of ANC visits [62, 65]. Basically, the four ANC visits were 
mainly suggested in consideration of women residing far 
from health facilities (HFs) [12]. However, having physical 
access to HFs is not enough in the acute and persistent short-
ages of drugs, medical equipment, other basic supplies, and 
HWs who are humane, skilled and motivated [42, 47, 66]. 
HFs may be closer, but the target users bypass them by con-
sulting the providers perceived as being more skilled for 
delivering better services [67]. Attendance to ANC gives the 
pregnant women an opportunity for accessing health educa-
tion (including counselling) related to their pregnancy and 
their children/babies [55]. None-regular ANC clinic at-
tendees for various reasons (including long travel distance) 
have limited accessibility to IPTp services in the right time 
such as during the early stages of pregnancy [32], including 
RCH education in general [68, 69].  
User Charges in General and in Relation to ANC Services  
 Experience from SSA shows that real or perceived exis-
tence of user-fees is a stumbling block to pregnant women’s 
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contact of RCH clinics [70]. In some areas of Tanzania [71], 
Uganda [72], Zimbabwe [73], Nigeria [74], and South Africa 
[75] user-fees have discouraged pregnant women with lim-
ited cash to attend ANC clinics. IPTp services are not neces-
sarily free of user-fee barriers [37], especially at private HFs 
[43, 76], as studies in several districts in Tanzania [38], Ma-
lawi [34] and Kenya, have elucidated. In Kenya, Lynm and 
Munguti found that even in government clinics the ANC 
clients were often asked to pay for SP, leading to lower up-
take of the IPTp doses recommended for such clients [34].  
 Implementing exemption policies for RCH services in 
SSA is hampered by the low translation of the exemption 
guidelines into practice at HF levels. For example, in 
Uganda [35], Ghana [77] and Tanzania [29, 78-80], pregnant 
women sometimes paid formally for laboratory tests, regis-
tration and an initial consultation fee, which were perceived 
as a heavy burden to such women. Outside the user-fee 
structure, there are other informal charges and other indirect 
cost hindering pregnant women’s health service utilisation 
[58]. Misunderstanding or ignorance of the user-fee structure 
and exemption policy contributes to lowering health service 
utilisation. For example, sometimes user-fee exemption 
guidelines are in place but the target populations do not use 
their opportunity to ask/claim for exemptions, as they do not 
know that they are eligible [81]. In Korogwe district, Tanza-
nia, the community was unhappy with pregnant women be-
ing required to pay for some RCH services contrary to what 
was believed to be the government policy entitling such 
women to be among the exempted vulnerable population 
groups [80].  
Socio-Cultural Barriers  
 The extent to which socio-cultural determinants of com-
pliance with drugs also play a role in the optimal utilisation 
of existing HF based services has not been adequately stud-
ied, especially in a problem solving approach to improve 
facility utilisation and women’s participation in the IPTp 
strategy [19]. Along with the financial barriers, it is widely 
evident that women in most developing countries are facing 
social-cultural barriers to their access to HFs delivering RCH 
services [70]. Such barriers have strong roots into gender 
imbalances beyond the HF settings limiting their autonomy 
and power to attend ANC clinics and use IPTp services [30, 
37], among other RCH services [82]. Shying away or fearing 
to reveal one’s pregnancy in the early stage is one of the bar-
riers [37], as validated by findings from Tanzania [33]. 
Sometimes women delay to attend ANC clinics due to lack 
of permission from their spouses [47]. Studies in Tanzania 
(Centre for Enhancement of Effective Malaria Interventions 
2006, unpublished Research Report) and The Gambia (Gates 
Malaria Partnership-DBL 2005, unpublished Consultancy 
Report) found that teenagers feared the severe legal and so-
cial implications of getting pregnant while schooling or be-
fore marriage. The two studies also found that delay in con-
tacting ANC clinics also occurred in (a) married women who 
carried pregnancies outside the wedlock or did not have so-
cially recognised partners (b) women aged from 35 years and 
above who shied away to be accompanied or seen by much 
younger pregnant women. Consequently, the pregnant 
women concerned did not access either one or both doses of 
IPTp and other ANC services.  
 Age may influence pregnant women prefer particular 
service providers. A study on the determinants of pregnant 
women’s use of IPTp services in Mufindi district, Tanzania 
[38] noted some older women disliking to be attended by the 
nurses whose ages were as low as the ages of such women’s 
daughters. Myths and unfound beliefs may also negatively 
affect ANC attendances. In Mukono district, Uganda, women 
delayed attending ANC clinics and lowly utilised ITNs and 
IPTp due to the prevailing community myth and belief that 
adolescent girls and primigravidæ were at low risk [35, 83]. 
Provider-Client Interactions and Perceptions of Quality of 
ANC in Generals 
 Supply and demand related factors in a general or the 
broad health service situation contribute influencing the tar-
get clients’ choice of the service. Women may delay or com-
pletely decline to attend clinic because they appreciate com-
parative better service they received from the TBAs who 
may also portray better attitude of friendliness and devoting 
more time for listening to their clients about their health and 
social problems. Also, by experiencing frequent shortages of 
needed medication at ANC clinic, women find such services 
unreliable while they do not suffer such experience at TBAs 
[72]. Women are disappointed when: they wait longer at the 
service delivery point, are mishandled by nurses, and lack of 
diagnostic facilities [35, 76, 84], avoid contacting clinics for 
ANC in fear of the lack of privacy at the consultation or bad 
language of the nurses [85], face unfriendly opening hours 
and/or unfair and unexpected costs [56]. The need for the 
skilled ANC staff in the health-care system is one of the pre-
requisites for attracting women to clinics [56]. Moreover, 
lack of- or shortage of the essential utilities such as cups at 
ANC level for use by the patients taking SP under DOT has 
constrained IPTp implementation in Tanzania, Uganda and 
Malawi [34]. Not all the ANC clients feel comfortable when 
they are required to share cups when taking the drugs under 
DOT for IPTp [86]. Generally, analysis of trends and levels 
of ANC service provision in Africa and other developing 
countries has revealed that the ANC service provided are 
substandard, therefore, significantly contributing to lower the 
uptake of such services [12, 34, 55, 56, 62, 67]. Vast litera-
ture documents the concern raised about the factors hinder-
ing pregnant women to attend clinics, but as Fathalla [87] 
argues, the key question service providers must ask them-
selves is, “do we offer the service that the women will ac-
cept?, instead of asking “why do women not accept the serv-
ice we offer?” [56].  
Perceptions and Acceptability of SP  
Psychological Barriers: Perspective of Pregnant Women 
and the Society Around them Concerning SP 
 Findings from SSA show pregnant women and the soci-
ety associating SP with severe adverse outcomes such as 
abortion, skin reaction and lack of anti-fever effect [14, 30, 
34, 35, 80, 83, 88-90]. Truly, SP can cause effects such as 
Stevens-Johnson syndrome in people who are allergic to 
sulfa with possible dramatic and potentially fatal effects [91-
94]. However, such side-effects are rare and in most cases 
exaggerated [10, 25, 95]. The perception people have on a 
drug may significantly determine their acceptance of that 
particular drug [37]. A drug that is bitter or associated with 
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abortion in some cultures is likely to be less complied with 
by the target population [96]. The situation is worse when 
health service providers share such sentiments and hence are 
unable to provide service users with correct information 
about the drug. In Tanzania, some health professionals ex-
pressed their doubts about the rationale for recommending 
SP for malaria treatment in areas where drug resistance is 
already high [97]. In Malawi, some HWs believed that SP 
was not appropriate to be taken by a person with an empty 
stomach [34].  
Health Care Workers’ Knowledge and Administration of 
IPTp-SP 
 It is important that health-care providers know well the 
health problems against which the services are provided. 
This includes knowledge on the causes, management and 
prevention of such problems (including diseases like ma-
laria), which is essential for their own motivation and confi-
dence in managing or giving advice to their clients [98]. One 
study in Kenya found that IPTp was not administered at 
some clinics due to HWs being unaware of the guidelines 
[14]. Similarly in Tanzania, HWs in two districts reported 
confusion they faced regarding timing of the doses and the 
number of the doses to be administered for IPTp [33]. In this 
circumstance of limited knowledge among the HWs, the 
effectiveness and coverage of health interventions remain to 
be undermined, and may expose the target populations to the 
risk of being attended by uninformed HWs [6]. A number of 
malaria control programmes deliberately emphasise initial 
training of HWs in order to improve their communication 
skills and prevent this negative effect [34].  
Health Service Providers’ Morale at their Workplaces, Per-
ceptions on SP and its Implications on ANC-IPTp  
 Reducing poverty by preventing malaria in pregnancy is 
among the MDGs [99, 100]. But serious shortage of skilled 
and motivated staff in SSA and other developing countries’ 
health sectors, is a conundrum [101]. The working environ-
ment may affect HWs’ morale and performance of different 
health interventions including IPTp. In Tanzania, Uganda 
and Zambia, HF understaffing contributed to HWs’ per-
ceived overwork, affecting the quality of care and HWs 
adherence to IPTp-DOT guidelines [34]. Also, poor infra-
structural status and low staff remuneration have demoral-
ized HWs and lowered the general quality of care in SSA 
[42, 102]. A recent review of country experiences indicated 
the shortage of water and cups at HFs having affected HWs’ 
adherence to DOT for IPTp in Tanzania and Uganda [34]. 
Several HWs in Dar es Salaam and Mkuranga district, Tan-
zania, reported the inconvenience faced due to wasting time 
and occasionally spending their out-of-pocket money finding 
water for use at clinic level (Mubyazi, PhD Thesis, submit-
ted). Most studies report the low quality of the health-care 
given by the nurses to discourage women in utilising RCH 
services. This is a reality, although it is important to consider 
the reasons for such HWs to behave/practice in the way they 
do rather than only accusing them. For instance, studies in 
Zimbabwe [103, 104] and Tanzania [84] found nurses com-
plaining to have been working under pressure and with little 
sympathy from their clients.  
 The issue of unofficial user-fees on the fee-empted RCH 
services discussed before can be connected to health service 
providers’ working condition. There is evidence that even 
when the HWs are informed of the exemption policy, they 
may still charge their clients due to poor remuneration and 
economic pressures to maintain their own good living [70]. 
ANC staff may also fail to administer SP not necessarily due 
to loss of interest, but pregnant women may hate taking SP, 
or due to drug shortages as noted in Tanzania [32], Kenya 
[14] and Malawi [34].  
 In areas where there is no service, outreach clinic serv-
ices are crucial to ensure physical accessibility [56]. Al-
though mobile clinics have been implemented in attempt to 
increase coverage of the remote and difficult-to-reach com-
munities, they are hampered by low morale of the HWs who 
dislike travelling to remote places. So far evidence shows 
that the IPTp strategy like other drug-based malaria interven-
tions is constrained by low outreach coverage [19]. In 
Korogwe district (Tanzania) district health management 
team (DHMT) reported lack of transport occasionally limit-
ing the DHMTs ability to reach remote HFs for health serv-
ice supervision as planned. Therefore, it was suggested that 
concerted efforts for improving HWs’ morale (including the 
issue of transport and number of HF staff) are necessary if 
compliance with IPTp service provision has to be realised 
[76].  
Achievements and Opportunities for IPTp-SP and ANC 
Services 
 Despite the constraints mentioned above, IPTp imple-
mentation in SSA in SSA is happening and there are indica-
tions that it is possible to attain the Abuja target of the 60% 
coverage of pregnant women receiving IPTp [7, 12]. Re-
cently, countries such as Kenya, Malawi and Tanzania have 
reached and even passed the 60% coverage of women attend-
ing ANC clinics for two or more times and in some districts 
IPTp coverage have reached >60% for the first dose [34, 
105]. There is also an encouraging trend in the coverage for 
the second dose although still less than 50% in Tanzania [33], 
as in many other countries in southern Africa [34, 105]. The 
IPTp coverage records are encouraging, though not much, 
from a policy and programme perspective. However, good 
access to ANC does not warrant high uptake of IPTp-SP, 
since quality of care delivery factors, HWs knowledge and 
motivations, and target population’s knowledge, attitudes 
towards IPTp and practices remain important [32-34, 47].  
DISCUSSION 
Importance of IPTp 
 There has been a common appreciation on importance of 
malaria IPTp in SSA. However, based on different authors’ 
observations, special consideration should be given to possi-
ble factors that may hinder the achievement of the desired 
level of coverage.  
Socio-Economic and Systemic Considerations  
Service Provision/Supply Issues 
 Advocacy for critical and broad analysis of factors affect-
ing malaria interventions [42] is supported by evidence elu-
cidated regarding the understaffing, shortage of utilities and 
drugs at a number of HFs. Low knowledge especially on the 
rationale and benefits of interventions may remain critical to 
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IPTp implementation if concerted efforts are not made to 
overcome the challenges. It is still critical as it allows low 
adherence to IPTp, false beliefs and perceptions, and may 
even bias the performance of the HWs. Informal visits to 
TBA is unlikely to cease in SSA communities, and despite 
the need for involving the TBAs in malaria prevention 
strategies, such providers should consider themselves as re-
placement of the formal ANC system, rather than comple-
menting it. Also, any view that the target service users are 
most likely to be less aware of a new intervention is not sup-
ported by evidence on the low knowledge on IPTp guide-
lines from a study of HWs [33-34]. This suggests that policy 
and programme authorities should continue considering the 
building the capacity of the existing HWs by allocating addi-
tional resources for training and emphasising on regular su-
pervision and periodically monitoring their performances.  
 Although some of the factors identified to lead to the low 
HWs’ morale, including understaffing, poor infrastructural 
facilities and unsatisfactory salaries may not be removed 
overnight, efforts are required towards improvement. Work-
ing on some of these problems may not only (and necessar-
ily) need additional financial resources, but (also) an im-
proved management system that allows responsiveness to 
local needs and accountability. HWs may not necessarily 
claim for increased salaries rather than needing timely remu-
neration packages.  
Service Demand Issues 
 User-fees may remain as a crucial health care financing 
mechanism both in the public and private sectors. Neverthe-
less, their implementation without affecting RCH services is 
questioned considering resource-poor settings where already 
pregnant women are constrained by other social-cultural 
gender biased conditions [70]. It should be remembered that 
poverty is rampant and both the pregnant women and the 
HWs are under undue economic pressures. Anything that 
may be used as an excuse to evade the pregnant women to 
attend HFs implementing user-fees will sound well to such 
women and add to reduction of the many roadblocks towards 
achieving the Abuja targets. Wrong beliefs about the inter-
vention may be minimised through equipping the HWs with 
current knowledge and improving their working conditions 
so that they can be better advocates for health interventions 
(including IPTp). To most of the service clients and even 
some health service providers, prevention benefits are not 
seen immediately. 
 Even in conditions where there might be an adequate 
supply of drugs, the target users may still hate taking it as 
reported above. The Health Belief and Behavioural Theories 
assert that people may only adapt a disease preventive meas-
ure if they believe that they are either susceptible to or 
threatened by the disease with perceived consequences, and 
in the case of prevention they weigh the benefits of adapting 
the recommended method against the undesirable risks, costs 
and other consequences [106, 107]. Therefore, the reported 
delay by women to attend clinics and their negative attitudes 
towards SP may also be rooted from their disregard of ma-
laria prevention through IPTp-SP, besides other reported 
barriers concerning imbalanced gender relations and poverty 
conditions facing most women in SSA.  
CONCLUSION 
 The implementation of IPTp in SSA is undoubtedly done 
in a multifaceted socio-economic and ANC resource con-
strained settings, this having an impact on the achievement 
of the Abuja targets. However difficult it might be, it is cru-
cial to get prepared for the challenges in attempt to minimise 
their impacts. As long as 5t 5s acknowledged that the bene-
fits outweigh the costs or risks, scaling-up IPTp to increase 
coverage is crucial, considering the severe consequences to 
the mother and offspring of malaria in pregnancy. Establish-
ing and using wider evidence-base may help to arrive at in-
formed policy and management decisions related to IPTp 
implementation. Currently, the evidence available regarding 
the determinants of ANC provision, utilisation and coverage 
is vast for decision makers to capitalise on the strengths and 
work on the existing challenges. The scaling-up of IPTp 
would benefit from applying knowledge acquired through 
research on the real situation and how to improve it. Yet, 
political will and taking action to provide moral and finan-
cial support on operational research are crucial. This would 
help monitoring what works and what does not in relation to 
ANC [71]. In principle, educating the general population is 
desirable to bring everybody at a good level of understand-
ing, hence enhancing compliance and coverage. Education 
and advocacy efforts must be continuous and their emphasis 
must be maintained at all the times. This requires a strong 
health system and revealed by this review, a robust health 
system is required for effective implementation of the IPTp 
strategy. The healthcare system must be strengthened by 
adequate staffing levels, sharpening staff skills and motivat-
ing them by improving the general staff working conditions. 
IPTp programme managers and frontline implementers at 
district level should be aware that not all HWs on malaria 
control services are fully knowledgeable about the interven-
tion strategy [33]. Special attention should therefore be paid 
to instil such knowledge and to monitor its implementation. 
Improving HWs’ morale to ensure durable effects requires 
the training of such workers and regularly supervising them, 
increasing the number of HWs, improving health infrastruc-
ture and working tools, and building trust and confidence 
among such workers and their service users. To make an 
important difference, operational health service and policy 
research should be an integral part of the intervention pro-
gramme [44]. Researchers should ensure that the translation 
of research evidence into systemic action requires timely 
conduction of research, submission of the research reports 
and in the form that can be easy to be used by decision mak-
ers [97]. 
RESEARCH AGENDA 
 This review suggests the need for understanding the (a) 
perceptions and attitudes of pregnant women, the general 
public and health service providers concerning IPTp-SP (b) 
the risk of ANC clients missing SP or getting it in a sub-
standard way (c) effect of user-fees on general services or 
ANC and indirect cost e.g. travel, waiting time on IPTp de-
livery and coverage (d) acceptability and practice of IPTp-SP 
in countries which have replaced SP with ACTs as the first-
line drug for uncomplicated malaria as some people may 
have now preferred drugs other than SP which may be seen 
to be no longer beneficial (f) the feasibility and viability of 
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IPTp in the existence of other malaria preventive methods 
that are promoted and implemented in different socio- cul-
tural and health care delivery settings [30, 108] (h) implica-
tions of HIV counselling and screening services on ANC 
attendances and delivery/uptake of IPTp-SP. We observe 
that in situations whereby women have to pay for the screen-
ing services or are stigmatised by HIV screening services at 
ANC clinics, the delivery of IPTp may be lowered by de-
creased women’s attendances. This observation is supported 
by other authors [109] who argue that in societies where 
women suffer abuse, social inequality and injustice, screen-
ing them for HIV at ANC clinics has both socio-cultural and 
ethical implications, which means ANC attendances may be 
reduced. The morbidity and mortality effects of malaria in 
pregnancy remain to be experienced if the apparently persis-
tent and increasing trend of P.falciparum resistance to the 
recommended drugs is not reversed. This is a challenge, call-
ing for the biomedical researchers to continue investigation 
towards discovery of alternative more effective drugs [110-
112].  
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